Global News | World latest News| Trending News
Newswise — Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A once-daily pill named PrEP, or pre-exposure prophylaxis, has been a stalwart for HIV prevention—but only if people take it consistently and can routinely access a pharmacy. In 2022, Gilead Sciences, Inc., received U.S. Food…
Newswise — The FDA recently approved a new drug that is highly effective at preventing HIV transmission with just two annual subcutaneous injections. In clinical trials, Lenacapavir was found to be nearly 100% effective in the prevention of HIV. Current prevention measures require patients to take medication daily or receive an injection six times a…
Newswise — Unfounded rumours have long circulated about Africans being injected with HIV for research purposes. But what about this: African soldiers getting their blood tested at a health centre in the early days of AIDS and then being injected with vaccines, all under the strictest secrecy? In the early 2000s, sociologist and pharmacist Pierre-Marie…
Newswise — The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development of lenacapavir, a medication used to treat and prevent human immunodeficiency virus (HIV) and the first approved drug to disrupt a viral capsid, a critical piece of the viral machinery that allows it to replicate….
Newswise — Igho Ofotokun, MD, MSc, FIDSA, will join University Hospitals as Chair of the Department of Medicine and Physician-in-Chief. Dr. Ofotokun will begin his role on Oct. 1, 2025. He will be nominated to serve as the STERIS Chair of Excellence in Medicine at UH. Dr. Ofotokun will also be nominated for appointment by Case…
BYLINE: By Jared Sagoff Though not a full vaccine yet, discovery shows important proof of concept that can neutralize a third of the strains of HIV in the U.S. Newswise — The human immunodeficiency virus (HIV) is one of the most common and deadly viruses known to mankind. Approximately 40 million people around the world are living…
Newswise — Accurate monitoring of CD4+ T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV). Yet conventional tools like flow cytometry, while highly effective, are expensive, complex, and ill-suited for widespread use in remote or resource-limited areas. Many portable alternatives remain constrained by low…
Newswise — Eight times more American young adults now take medication to protect them from HIV than a decade ago, a new study finds. But even with this positive news about increasing use of pre-exposure prophylaxis or PrEP, the study also suggests that health care providers and public health agencies could do more to promote…
Newswise — Prevention and treatment campaigns are not adequately targeting the particular needs of the 50+ years age group. Indeed, between 2000 and 2016, the number of adults aged 50 years and older living with HIV in sub-Saharan Africa doubled. At present, their HIV prevalence is exceeding that of younger adults. By 2040, one-quarter of people living…
Newswise — TAMPA, Fla. (May 5, 2025) — People living with HIV are less likely to receive potentially lifesaving cancer treatment if they live in communities with lower income levels and educational attainment, according to a new national study led by researchers from Moffitt Cancer Center. In the study, published in Cancer, researchers looked at…
